Important Reminder for MoonLake Investors About Class Action Lawsuit With Deadline Approaching

Legal Alert for MoonLake Investors

Levi & Korsinsky, LLP is reaching out to investors of MoonLake Immunotherapeutics (NASDAQ: MLTX) regarding an impending class action lawsuit. This legal proceeding is particularly noteworthy for those who believe they have suffered losses due to alleged securities fraud occurring between March 10, 2024, and September 29, 2025. Investors are encouraged to review the details and act before the lead plaintiff deadline on December 15, 2025.

Overview of the Class Action Lawsuit

The lawsuit stems from various false statements made by the company's defendants, which may have misled investors about the company’s drug candidate, SLK. The core issues being raised in the lawsuit include:
1. The assertion that SLK and BIMZELX target the same inflammatory cytokines IL-17A and IL-17F, suggesting a lack of unique efficacy for SLK.
2. Claims that SLK’s distinct Nanobody structure does not provide any significant clinical advantage over BIMZELX’s traditional monoclonal structure.
3. Questions surrounding SLK’s claimed superior tissue penetration and its actual clinical impact.
4. Allegations that defendants did not possess sufficient factual basis to make their positive claims regarding SLK.

How Investors Can Participate

If you fall within the affected timeline and experienced financial losses related to your investment in MoonLake, it's crucial to act promptly. You have until December 15, 2025, to apply for appointment as the lead plaintiff in this class action suit. However, even if you do not wish to take on the lead plaintiff role, you may still be eligible to receive potential compensation without incurring any out-of-pocket expenses or obligations.

No Cost Participation

Investors should be reassured that participation in this class action will not require any upfront payments. Those affected can submit their inquiries through the MoonLake Lawsuit Submission Form provided by Levi & Korsinsky. This firm is well-regarded in the field of securities litigation, boasting over two decades of experience in obtaining significant recoveries for investors.

Levi & Korsinsky’s Expertise

With a dedicated team of over 70 legal professionals specializing in securities litigation, Levi & Korsinsky has built a formidable reputation in the legal industry. For seven consecutive years, they have been recognized among the top 50 securities litigation firms in the United States by ISS Securities Class Action Services. Their extensive track record demonstrates a commitment to serving investors facing complex legal challenges stemming from securities fraud.

Contact Information

For more information or to take the next steps, affected investors can reach out to Joseph E. Levi, Esq. at Levi & Korsinsky by phone at (212) 363-7500 or via their official email. The firm is located at 33 Whitehall Street, 17th Floor, New York, NY 10004.

Conclusion

As the deadline approaches, MoonLake investors need to stay vigilant and informed. Whether through seeking compensation or merely staying updated, investors must recognize the importance of the ongoing class action lawsuit and consider the legal options available to them.